Please login to the form below

Not currently logged in
Email:
Password:

disenchantment

This page shows the latest disenchantment news and features for those working in and with pharma, biotech and healthcare.

The death of deference

The death of deference

One social factor, important to the rise of the life science industry, that is rarely discussed was disenchantment. ... In my work, I discern a 21st century parallel to disenchantment, namely the 'death of deference'.

Latest news

  • History rhymes: modern globalisation trends mirror the past History rhymes: modern globalisation trends mirror the past

    It's not hard to see parallels with our connected world. And at the same time, the sociologist Weber recorded 'The Age of Disenchantment' as the public began to move its

  • Building a good defence

    Disenchantment discontinuers are different. Research shows that, barring a major safety event or government directive, the main reason for disenchantment is simply misinformation; confusion, conflicting messages or incomplete understanding.

  • NHS news in brief

    ìIt would seem that disenchantment with the government translates into scepticism about the service.î.

  • Question Master

    Like all potentially great ideas, an excess of enthusiasm might be followed by disenchantment if patient-reported health questionnaires became the fashion and practice of all Trusts over night.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics